Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model
- PMID: 23137377
- DOI: 10.1021/mp3004308
Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model
Abstract
Human cerebral microvascular endothelial cell line hCMEC/D3 is an established model of the human blood-brain barrier (BBB). The purpose of the present study was to determine, by means of quantitative targeted absolute proteomics, the protein expression levels in hCMEC/D3 cells of multiple transporters, receptors and junction proteins for comparison with our previously reported findings in isolated human brain microvessels. Among 91 target molecules, 12 transporters, 2 receptors, 1 junction protein and 1 membrane marker were present at quantifiable levels in plasma membrane fraction of hCMEC/D3 cells. ABCA2, MDR1, MRP4, BCRP, GLUT1, 4F2hc, MCT1, ENT1, transferrin and insulin receptors and claudin-5 were detected in both hCMEC/D3 cells and human brain microvessels. After normalization based on Na(+)/K(+) ATPase expression, the differences in protein expression levels between hCMEC/D3 cells and human brain microvessels were within 4-fold for these proteins, with the exceptions of ENT1, transferrin receptor and claudin-5. ABCA8, LAT1, LRP1 and γ-GTP were below the limit of quantification in the cells, but were found in human brain microvessels. ABCA3, ABCA6, MRP1 and ATA1 were found only in hCMEC/D3 cells. Furthermore, compared with human umbilical vein endothelial cells (HUVECs) as reference nonbrain endothelial cells, MDR1 was found only in hCMEC/D3 cells, and GLUT1 expression was 15-fold higher in hCMEC/D3 cells than in HUVECs. In conclusion, this is the first study to examine the suitability and limitations of the hCMEC/D3 cell line as a BBB functional model in terms of quantitative expression levels of transporters, receptors and tight junction proteins.
Similar articles
-
Large-Scale Quantitative Comparison of Plasma Transmembrane Proteins between Two Human Blood-Brain Barrier Model Cell Lines, hCMEC/D3 and HBMEC/ciβ.Mol Pharm. 2019 May 6;16(5):2162-2171. doi: 10.1021/acs.molpharmaceut.9b00114. Epub 2019 Apr 15. Mol Pharm. 2019. PMID: 30983357
-
Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3.Brain Res. 2010 Oct 1;1354:15-22. doi: 10.1016/j.brainres.2010.07.077. Epub 2010 Aug 6. Brain Res. 2010. PMID: 20692239
-
Hypoxia interferes with aryl hydrocarbon receptor pathway in hCMEC/D3 human cerebral microvascular endothelial cells.J Neurochem. 2015 Feb;132(4):373-83. doi: 10.1111/jnc.12972. Epub 2014 Nov 14. J Neurochem. 2015. PMID: 25327972
-
Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.Curr Drug Metab. 2013 Jan;14(1):120-36. Curr Drug Metab. 2013. PMID: 23215812 Review.
-
Quantitative targeted proteomics for understanding the blood-brain barrier: towards pharmacoproteomics.Expert Rev Proteomics. 2014 Jun;11(3):303-13. doi: 10.1586/14789450.2014.893830. Epub 2014 Apr 4. Expert Rev Proteomics. 2014. PMID: 24702234 Review.
Cited by
-
A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J mice.Fluids Barriers CNS. 2013 Jun 8;10(1):21. doi: 10.1186/2045-8118-10-21. Fluids Barriers CNS. 2013. PMID: 23758935 Free PMC article.
-
Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier.Fluids Barriers CNS. 2018 Oct 19;15(1):30. doi: 10.1186/s12987-018-0113-6. Fluids Barriers CNS. 2018. PMID: 30340614 Free PMC article. Review.
-
Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells.Cells. 2022 Dec 8;11(24):3963. doi: 10.3390/cells11243963. Cells. 2022. PMID: 36552728 Free PMC article.
-
Maternal and Fetal Expression of ATP-Binding Cassette and Solute Carrier Transporters Involved in the Brain Disposition of Drugs.Adv Exp Med Biol. 2023;1428:149-177. doi: 10.1007/978-3-031-32554-0_7. Adv Exp Med Biol. 2023. PMID: 37466773
-
Diet-induced obesity suppresses expression of many proteins at the blood-brain barrier.J Cereb Blood Flow Metab. 2014 Jan;34(1):43-51. doi: 10.1038/jcbfm.2013.166. Epub 2013 Sep 25. J Cereb Blood Flow Metab. 2014. PMID: 24064496 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous